{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:21:46Z","timestamp":1710202906759},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-02835-2","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T13:02:53Z","timestamp":1709298173000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitiligo is associated with new-onset osteoporosis: a retrospective cohort study"],"prefix":"10.1007","volume":"316","author":[{"given":"Naama Tova","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanette B.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalaf","family":"Kridin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"issue":"2","key":"2835_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24966\/CDT-8771\/100039","volume":"5","author":"AA Mohamed Amer","year":"2019","unstructured":"Mohamed Amer AA (2019) Correlation between vitamin D and interleukin - 21 in patients with vitiligo. Clin Dermatol Ther 5(2):1\u20134","journal-title":"Clin Dermatol Ther"},{"issue":"6","key":"2835_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.4103\/0019-5154.169123","volume":"60","author":"RW Doss","year":"2015","unstructured":"Doss RW, E-Ragyr LA (2015) Vitamin D receptor expression in vitiligo. Indian J Dermatol 60(6):544\u2013548","journal-title":"Indian J Dermatol"},{"issue":"13","key":"2835_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21134749","volume":"21","author":"MM Sirufo","year":"2020","unstructured":"Sirufo MM, De Pietro F, Bassino EM, Ginaldi L, De Martinis M (2020) Osteoporosis in skin diseases. Int J Mol Sci 21(13):1\u201317","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2835_CR4","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.1111\/jocd.15272","volume":"21","author":"AM Beyzaee","year":"2022","unstructured":"Beyzaee AM, Goldust M, Patil A, Rokni GR, Beyzaee S (2022) The role of cytokines and vitamin D in vitiligo pathogenesis. J Cosmet Dermatol 21(11):6314\u20136325","journal-title":"J Cosmet Dermatol"},{"issue":"6","key":"2835_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jbspin.2010.09.018","volume":"77","author":"X Guillot","year":"2010","unstructured":"Guillot X, Semerano L, Saidenberg-Kermanac\u2019h N, Falgarone G, Boissier MC (2010) Vitamin D and inflammation. Joint Bone Spine 77(6):552\u2013557","journal-title":"Joint Bone Spine"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-02835-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T17:03:10Z","timestamp":1710176590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-02835-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":5,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["2835"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-02835-2","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Nanette B Silverberg is a speaker or advisor for Verrica, Novan, Regeneron, Sanofi, and Incyte Pharmaceuticals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"94"}}